Stifel Nicolaus & Co. and a female worker who alleged sexual assault, harassment, and retaliation against the wealth ...

Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on Altimmune (ALT – Research Report) today and set a price target of $18.00. The ...

Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on RegenXBio (RGNX – Research Report) today and set a price target of $40.00.

Stifel Financial was ordered by a Financial Industry Regulatory Authority arbitration panel to pay a family $132.5 million ...

Keefe, Bruyette & Woods, Inc., a leading specialist investment bank to the financial services and fintech sectors, and a ...

A three-person arbitration panel overseen by Finra Dispute Resolution Services stunned the financial advice industry on ...

Stock analysts at Stifel Nicolaus initiated coverage on shares of Cameco (NYSE:CCJ – Get Free Report) (TSE:CCO) in a research ...

A Finra panel ruled the firm's conduct overconcentrated the family in structured notes and limited industries.

Siegmann Brings Extensive Industry & Investment Experience to StifelST. LOUIS, March 10, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today appointed Jonathan Siegmann as Managing ...

Savaria (TSE:SIS – Free Report) had its price target decreased by Stifel Nicolaus from C$25.00 to C$24.00 in a report ...

Detailed price information for Scotts Miracle-Gro Company (SMG-N) from The Globe and Mail including charting and trades.

Stifel, Nicolaus & Company subsidiary to pay ~$132M in a dispute over its investment recommendations, the firm disclosed on Thursday. The company plans to seek a judicial review of the award, which it ...